Author/Authors :
Singh, Baljit Graduate Medical Education - St. John Hospital and Medical Center, Detroit, MI, USA , Ip, Randy Graduate Medical Education - St. John Macomb-Oakland Hospital, Detroit, MI, USA , Al-Rajjal, Ahmed Ibrahim Graduate Medical Education - St. John Hospital and Medical Center, Detroit, MI, USA , Kafri, Zyad Van Elslander Cancer Center - Grosse Pointe Woods, MI, USA , Al-Katib, Ayad Van Elslander Cancer Center - Grosse Pointe Woods, MI, USA , Hadid, Tarik Van Elslander Cancer Center - Grosse Pointe Woods, MI, USA
Abstract :
Primary cardiac lymphoma (PCL) is a rare neoplasm that involves the heart, pericardium, or both. Patients with PCL have median
survival of approximately 7 months. We report a 63-year-old woman with PCL treated with chemoimmunotherapy but relapsed 7
years later. She received automated implantable cardioverter-defibrillator (AICD) prophylactically shortly after the diagnosis. She
presented with a breast recidive 7 years after initial diagnosis and died of relapsed small cell lung cancer. As many patients with PCL
die early in the disease course due to life-threatening arrhythmias, preemptive implantation of AICD may improve mortality and
prevent early death. Chemoimmunotherapy is effective in inducing remission in patients with PCL. Late and unusual pattern of
relapse may be more frequent in patients with PCL and should be explored further. This case presents one of the longest surviving
patients with PCL reported in the literature.
